Related by context. All words. (Click for frequent words.) 75 lipid levels 72 metabolic parameters 72 serum lipids 71 serum lipid 71 plasma lipids 71 lipid profile 70 insulin sensitivity 69 fasting insulin 69 lipid parameters 68 glycosylated hemoglobin HbA1c 68 glucose tolerance 68 cardiometabolic risk 68 glycemia 68 HDL cholesterol triglycerides 68 triacylglycerol concentrations 68 fasting glucose levels 68 adiponectin levels 68 endothelial function 67 triglyceride concentrations 67 glycosylated hemoglobin levels 66 adrenal function 66 serum lipid levels 66 plasma lipid 66 blood lipids 66 plasma triglycerides 66 intima media thickness 66 serum cholesterol 66 carotid IMT 66 glucose insulin 66 arterial stiffness 66 cardiorespiratory fitness 66 inflammatory biomarkers 65 flow mediated dilation 65 HbA1C levels 65 LDL cholesterol concentrations 65 neurocognitive function 65 HbA 1c 65 cholesterol triglycerides 65 LDL HDL 65 fasting serum 64 urinary albumin 64 fasting plasma glucose 64 blood lipid profiles 64 glucose homeostasis 64 peak VO2 64 dietary carbohydrate 64 serum vitamin D 64 blood glucose concentrations 64 hydroxyvitamin D levels 64 antioxidant supplementation 64 magnesium intake 64 dyslipidaemia 64 hemoglobin A1c levels 64 body fatness 64 Insulin sensitivity 64 serum triglycerides 64 triglyceride levels 64 fats lipids 64 total cholesterol triglycerides 64 homocysteine concentrations 63 cognitive function 63 improves insulin sensitivity 63 Fasting glucose 63 serum uric acid 63 paricalcitol 63 serum calcium 63 HbA1c levels 63 fasting glucose 63 cardiovascular morbidity 63 glycemic control 63 extrapyramidal symptoms 63 cholesterol HDL cholesterol 63 hemoglobin A1C 63 nonfasting 63 serum leptin 63 APOE genotype 63 thyroid hormone levels 63 dietary supplementation 63 serum BDNF 63 cardio respiratory fitness 63 NPH insulin 63 intact parathyroid hormone 63 diastolic function 63 β blockers 63 Calcium intake 62 antioxidant intake 62 HOMA IR 62 hemoglobin A1c HbA1c 62 lipoprotein levels 62 serum concentrations 62 fasting blood glucose 62 albumin excretion 62 postprandial glucose 62 serum urate levels 62 triglycerides 62 antihypertensive medications 62 carbohydrate metabolism 62 abnormal lipid levels 62 fasting plasma glucose FPG 62 tertiles 62 HDL LDL 62 plasma homocysteine 62 dietary intake 62 plasma lipoprotein 62 dietary fatty acids 62 colorectal adenoma 62 HbA1C 62 Fasting plasma glucose 62 abdominal adiposity 62 VLDL cholesterol 62 Endothelial function 62 postprandial glycemia 62 nonfasting triglyceride levels 62 serum triglyceride levels 62 CLA supplementation 62 neurocognitive functioning 62 density lipoprotein cholesterol 62 myocardial uptake 62 visceral adiposity 62 Stop Hypertension diet 62 impaired glucose metabolism 62 dietary folate 62 metabolite concentrations 62 salivary cortisol 62 glycemic diet 62 waist circumference WC 62 BMI z 61 apolipoprotein B 61 peptide YY 61 calcium supplementation 61 inflammatory markers 61 HRQL 61 neurodevelopmental outcomes 61 fasting plasma 61 serum PTH 61 dietary calcium intake 61 psychosocial functioning 61 hsCRP 61 elevated LDL cholesterol 61 metabolic disturbances 61 liver histology 61 adiposity 61 fructosamine 61 neurodevelopmental outcome 61 hsCRP levels 61 postprandial glucose levels 61 estrogen metabolism 61 vessel dilation 61 psychosocial variables 61 HRQOL 61 DASH diet 61 endothelium dependent 61 antihypertensive therapy 61 bile acid metabolism 61 lipoprotein profiles 61 antidiabetic medications 61 atherogenic 61 LDL cholesterol HDL cholesterol 61 arterial elasticity 61 subclinical atherosclerosis 61 serum retinol 61 Secondary efficacy endpoints 61 AST ALT 61 aminotransferases 61 elevated fasting glucose 61 glomerular filtration 61 HbA 1c levels 61 vascular reactivity 61 serum glucose 61 C reactive protein 61 glycated hemoglobin levels 61 elevated triglycerides 61 protein excretion 61 antidiabetic medication 61 mitochondrial function 61 fasting triglycerides 61 hormones leptin 61 hypertensives 61 platelet inhibition 61 pharmacokinetic PK profile 61 Unsaturated fats 61 metabolic abnormalities 61 atherogenic dyslipidemia 61 lipid concentrations 61 HDL LDL ratio 61 cholesterols 61 Hb A1C 61 LDL triglycerides 61 insulin resistance 61 ATACAND 61 tHcy 61 intima media thickness IMT 61 metabolic syndrome MetS 61 creatinine levels 61 triacylglycerol 60 modifiable lifestyle 60 pulmonary capillary wedge 60 hematological parameters 60 adiponectin concentrations 60 dietary modification 60 abnormal lipid 60 serum phosphate levels 60 apolipoproteins 60 cholesterol HDL 60 gallstone disease 60 dietary DHA 60 LDL HDL ratio 60 glycosylated hemoglobin 60 creatine supplementation 60 cholesterol LDL 60 macronutrient intake 60 carotid artery intima media 60 cardioprotection 60 urinary oxalate 60 peripheral insulin sensitivity 60 SHBG levels 60 HDL Cholesterol 60 arterial stiffening 60 abnormal lipids 60 thyrotropin levels 60 LDL cholesterol levels 60 mineral density 60 cardioprotective effects 60 abnormal glucose tolerance 60 visceral fat accumulation 60 lipoprotein 60 lipoprotein metabolism 60 urate levels 60 serum parathyroid hormone 60 serum insulin 60 c reactive protein 60 glycated hemoglobin HbA1c 60 chlorthalidone 60 carotid bruit 60 Atkins dieters cardiovascular 60 pyridostigmine 60 antihypertensive drugs 60 urinary calcium 60 lipid lowering agents 60 total cholesterol LDL 60 pharmacodynamic parameters 60 Carbohydrate intake 60 umol L 60 cardio protective 60 vasodilatation 60 selenium supplementation 60 neurologic outcomes 60 nonfasting triglycerides 60 dietary intakes 60 intestinal motility 60 apolipoprotein A1 60 plasma homocysteine levels 60 plasma folate 60 vascular dysfunction 60 vitamin supplementation 60 alanine aminotransferase 60 acarbose 60 Subgroup analyzes 60 carotid artery thickness 60 cardio metabolic 60 carotid plaque 59 nutrient intake 59 thyroid stimulating hormone 59 sitosterol 59 mixed hyperlipidemia 59 serum potassium 59 8 OHdG 59 intestinal permeability 59 serum creatinine levels 59 trans palmitoleate 59 serum homocysteine 59 dietary interventions 59 serum calcium levels 59 HRQoL 59 antihypertensive medication 59 baroreflex sensitivity 59 hippocampal volume 59 urinary excretion 59 HDL C 59 Triglyceride levels 59 carotid intima media 59 NHANES III 59 dietary glycemic index 59 potentially modifiable 59 angiotensin II receptor blockers 59 fat oxidation 59 cardiovascular disease hypertension 59 central adiposity 59 anthropometric measures 59 leukocyte counts 59 echocardiographic parameters 59 lipid abnormalities 59 CVD mortality 59 distensibility 59 thyrotropin 59 serum cortisol 59 bone metabolism 59 olmesartan 59 eicosapentaenoic acid 59 albumin excretion rate 59 lipid lowering therapy 59 NYHA functional class 59 atherogenic lipids 59 lung function 59 folate supplementation 59 Stop Hypertension DASH diet 59 BMI waist circumference 59 waist girth 59 exhaled nitric oxide 59 coronary calcification 59 bezafibrate 59 dietary antioxidants 59 endometrial thickness 59 transferrin saturation 59 MetS 59 adiponectin 59 Pioglitazone 59 systolic function 59 Subgroup analysis 59 LDL particle 59 plasma leptin 59 benazepril 59 plasma adiponectin 59 improving insulin sensitivity 59 locomotor activity 59 endothelial dysfunction 59 Cardiorespiratory fitness 59 Reynolds Risk Score 59 artery elasticity 59 hemodynamic parameters 59 lipid metabolism 59 Lp PLA 2 59 endometrial hyperplasia 59 insulin detemir 59 serum ferritin 59 uric acid levels 59 serum phosphate 59 elevated triglyceride levels 59 triglycerides TG 59 circulating estrogens 59 inotropic agents 59 posttransplant 59 oral antidiabetic medication 59 symptomatic VTE 59 growth hormone secretion 59 BENICAR HCT 59 nutrient intakes 59 MMSE scores 59 nondiabetic patients 59 dose proportionality 59 PANSS scores 59 glucose lowering 59 magnesium supplementation 59 nondiabetics 59 elevated homocysteine 59 hyperhomocysteinemia 59 triacylglycerols 59 airway responsiveness 59 normotensive 59 flecainide 59 serum PSA 59 serum selenium 59 CC genotype 59 tumor histology 59 hypercalciuria 59 cardioprotective effect 59 MUFAs 59 creatinine ratio 59 cardiac autonomic 59 diastolic BP 59 biochemical markers 59 Hp2 2 59 hypertension diabetes mellitus 59 NNT = 58 alanine aminotransferase ALT 58 glycaemia 58 pharmacokinetic parameters 58 systolic diastolic 58 fasting triglyceride levels 58 rosuvastatin Crestor 58 T1DM 58 Logistic regression analysis 58 pentoxifylline 58 improves glycemic 58 estrone 58 Waist circumference 58 autonomic dysfunction 58 exploratory endpoints 58 bone density 58 triglycerides LDL 58 elevated uric acid 58 muscle protein synthesis 58 plasma glucose 58 LDL cholesterol lowering 58 intestinal microflora 58 hypercholesterolaemia 58 hydroxy vitamin D 58 impaired endothelial 58 lumbar spine bone 58 serum estradiol 58 sulphonylureas 58 triiodothyronine 58 Singh Manoux 58 tissue oxygenation 58 diabetic polyneuropathy 58 platelet activation 58 baseline HbA1c 58 Lipoic acid 58 lipid lowering medications 58 A1c levels 58 erection hardness 58 serum IGF 58 abdominal circumference 58 hemodynamics 58 triglyceride lowering 58 Hemoglobin A1c 58 insulin sensitizing drug 58 lowest tertile 58 glucose uptake 58 BMI percentile 58 pleiotropic effects 58 algal DHA 58 postoperative AF 58 Primary endpoints 58 diastolic blood pressures 58 triglyceride TG 58 left ventricular systolic 58 coronary artery calcification 58 GH deficiency 58 QoL 58 folic acid intake 58 arterial thickening 58 systolic BP 58 d dimer 58 creatine kinase 58 thiazide 58 phylloquinone 58 thickness CIMT 58 Epidemiologic studies 58 eosinophil count 58 fasting lipid 58 macrovascular events 58 troponin T 58 overactive bladder symptoms 58 elevated creatinine 58 glucose metabolism 58 Hypoglycaemia 58 irbesartan 58 systolic blood pressure 58 tHcy concentrations 58 telomere lengths 58 Symptom severity 58 sperm morphology 58 neurohormonal 58 blood glucose levels 58 SGPT 58 lowering systolic blood 58 nondiabetic 58 serum GGT 58 Thiazolidinediones 58 IDDM 58 hyperlipidaemia 58 brachial artery flow 58 triglyceride 58 BCAAs 58 hemoglobin concentration 58 depressive symptomatology 58 probiotic supplementation 58 glycogen metabolism 58 lispro 58 folate intake 58 pulmonary arterial 58 serum folate 58 Lp PLA2 58 HDL cholesterol 58 N telopeptide 58 glucose concentrations 58 CPAP adherence 58 ursodeoxycholic acid 58 Observational studies 58 diuretics beta blockers 58 Fasting blood glucose 58 insulin sensitizing drugs 58 oxidized LDL 58 prostate carcinogenesis 58 primary aldosteronism 58 ovarian hormones 58 sociodemographic characteristics 58 hormone adiponectin 58 neuropsychiatric symptoms 58 postprandial blood glucose 58 sociodemographic variables 58 QTc intervals 58 endothelial activation 58 folate deficiency 58 HIV HCV coinfected 58 dyslipidemia abnormal 57 urinary N telopeptide 57 metabolizing enzyme 57 macrophage infiltration 57 lactate dehydrogenase 57 hepatic function 57 stimulated insulin secretion 57 cardiovascular mortality 57 symptomatic intracerebral hemorrhage 57 glycated hemoglobin 57 testosterone supplementation 57 symptom severity 57 candesartan cilexetil 57 aortic stiffness 57 cardiovascular calcification 57 tic severity 57 Concord grape juice 57 SGRQ 57 renal function 57 induced ischemia 57 A1C levels 57 platelet reactivity 57 pharmacodynamic effects 57 antidiabetic drugs 57 tibolone 57 microcirculatory 57 triglycerides HDL 57 cardiorespiratory endurance 57 carbohydrate restriction 57 LDL cholesterol 57 sibutramine Meridia 57 hyperphenylalaninemia HPA due 57 metabolic dysfunction 57 nonobese 57 hypercholesterolemic 57 macrovascular disease 57 postmenopausal breast cancer 57 soluble CD# ligand 57 Soy isoflavones 57 vasomotor symptoms 57 glycemic load 57 comorbid depression 57 ApoA1 57 HMG CoA reductase inhibitor 57 urinary albumin excretion 57 serum biomarkers 57 ghrelin concentrations 57 abdominal obesity 57 ALLHAT 57 choline intake 57 stone formers 57 lowers blood glucose 57 gliclazide 57 hepatic glucose production 57 LDL lowering 57 fluvastatin 57 flutamide 57 atypical neuroleptics 57 cerebral oxygenation 57 urolithiasis 57 shorter telomere length 57 PCWP 57 dapagliflozin plus 57 Fatty acid 57 Avandia Actos 57 chromium picolinate supplementation 57 pravastatin therapy 57 neutrophil counts 57 oral glucose tolerance 57 folic acid vitamin B6 57 -#.# ± [002] 57 antibody titer 57 prostate cancer CaP 57 folate vitamin B# 57 ischemic cardiovascular 57 RBP4 57 clinically meaningful 57 antipsychotic induced 57 endocrinologic 57 metformin sulfonylurea 57 serum phosphorous 57 metabolic 57 serum TSH 57 inversely associated 57 depot medroxyprogesterone acetate 57 Multivariate analysis 57 multivariate adjustment 57 interleukin IL -6 57 genetic polymorphisms 57 adenoma recurrence 57 HbA 1C 57 SGOT 57 Essential fatty acids 57 disease NAFLD 57 riociguat 57 handgrip strength 57 left ventricular hypertrophy 57 myocardial reperfusion 57 multiple logistic regression 57 lumbar spine BMD 57 statins cholesterol lowering 57 CHD mortality 57 left ventricular diastolic 57 #mg/dL [001] 57 dehydroepiandrosterone sulfate 57 poor metabolizers 57 CaPre ™ 57 coadministration 57 cardiac repolarization 57 waist circumference 57 methylphenidate MPH 57 thiazide diuretics 57 hepatic fibrosis 57 serum albumin 57 pharmacological therapies 57 CONCERTA ® 57 metformin sulphonylurea 57 induce insulin resistance 57 L arginine 57 blood Phe levels 57 univariate analyzes 57 hepatic enzymes 57 homocysteine levels 57 sociodemographic factors 57 elevated IOP 57 angiotensin converting enzyme 57 glucocorticoid hormones 57 Depressive symptoms 57 remnant lipoproteins 57 #.#mmHg 57 capillary density 57 neurohormones 57 Adequate vitamin D 57 tolerability profiles 57 Baseline characteristics 57 Secondary endpoints 57 prolactin levels 57 highest tertile 57 Thyroxine 57 total cholesterol HDL 57 plasma renin activity 57 hepatic fat 57 WOMAC pain 57 carbohydrate absorption 57 intensive statin therapy 57 bone mineral 57 nondiabetic subjects 57 Calcium vitamin D 57 HbA1c 57 meta regression 57 T2DM 57 Wactawski Wende 57 urine albumin 57 cholesterol LDL C 57 corrected QT interval 57 serum LDL cholesterol 57 Caloric intake 57 artery stenosis 57 Stop Hypertension 57 postprandial hyperglycemia 57 fatty acid oxidation 57 serum folate concentrations 57 Palatinose ™ 57 multivitamin supplements 57 macrovascular 57 lipid lowering therapies 57 tolvaptan 57 Homocysteine 56 serum cotinine levels 56 leptin concentrations 56 AVANDIA 56 hypercholesterolemia 56 coagulation parameters 56 insulin sensitizing 56 pressure natriuresis 56 statin monotherapy 56 estrogen metabolites 56 trigylcerides 56 cortisol secretion 56 clinically meaningful reductions 56 LDL Cholesterol 56 lowering blood glucose 56 receptor blockers 56 familial clustering 56 carotid stenosis 56 parathyroid hormone PTH 56 #mmHg [001] 56 overt nephropathy 56 KIF6 carriers 56 ß carotene 56 antitumor efficacy 56 fibrosis progression 56 pressor response 56 chromium supplementation 56 Cotinine 56 hypogonadal 56 vildagliptin 56 hydroxyvitamin D concentrations 56 lipoprotein profile 56 thyroxine 56 Univariate analysis 56 acetyl L carnitine 56 cortisol concentrations 56 Oxidized LDL 56 aspartate aminotransferase AST 56 Lipoprotein 56 Low density lipoprotein 56 carotid atherosclerosis 56 antioxidative 56 platelet function 56 glitazones 56 plasma pharmacokinetics 56 pulmonary function 56 HMG CoA reductase inhibitors 56 calcium Vitamin D 56 progestin therapy 56 alfuzosin 56 microalbuminuria 56 hMG 56 airway reactivity 56 VADT 56 polyunsaturated fatty acids PUFAs 56 mammographic density 56 pituitary hormone 56 aspartate aminotransferase 56 Cochrane reviewers 56 C Reactive Protein 56 cerebral microbleeds 56 diabetic dyslipidemia 56 pulmonary artery pressure 56 oral antidiabetic drugs 56 parasympathetic tone 56 #mg/day [002] 56 glycemic variability 56 hemodilution 56 biochemical abnormalities 56 Hcy 56 DASH Dietary Approaches 56 impair fertility 56 mm Hg systolic 56 Vigorous exercise 56 Cystatin C 56 acamprosate 56 hyperglycaemia 56 calcium excretion 56 ADAS Cog 56 MMSE score 56 Triglyceride 56 Calorie restriction 56 oxidized LDL cholesterol 56 cognitive functioning 56 TC HDL 56 gastrointestinal absorption 56 oxcarbazepine 56 creatinine clearance 56 fructose intake 56 nephrolithiasis 56 obese postmenopausal 56 subclinical hypothyroidism 56 loop diuretics 56 dietary patterns 56 vitamin B# supplements 56 multivariable analysis 56 calcium intakes 56 MTHFD1L gene 56 aldosterone antagonists 56 Lipid Profile 56 erythropoietic 56 reticulocytes 56 #OHD levels 56 ginkgo biloba extract 56 myeloperoxidase 56 -#.# mg dL [002] 56 C telopeptide 56 daytime alertness 56 calcium antagonists 56 iron chelators 56 atherosclerotic disease 56 hyperinsulinemia 56 L lysine 56 urinary protein 56 airway hyperresponsiveness 56 pramlintide 56 IPAH 56 calcium homeostasis 56 coronary microvascular 56 dose atorvastatin 56 hip BMD 56 calcium phosphorus 56 bad cholesterol LDL 56 carbohydrate diets 56 beta carotene supplementation 56 thiazide diuretic 56 intestinal absorption 56 subclinical hyperthyroidism 56 serum bicarbonate 56 folate intakes 56 pioglitazone HCl 56 diastolic pressures 56 polycystic ovary syndrome PCOS 56 antioxidant nutrients 56 multivitamin supplementation 56 TT genotype 56 Topiramate 56 -#.# mg dL [001] 56 NATRECOR ® 56 QTc 56 systolic hypertension 56 Logistic regression 56 losartan Cozaar 56 nitrotyrosine 56 arterial inflammation 56 pathophysiological mechanisms 56 insulin resistance syndrome 56 Genetic variants 56 β carotene 56 cerebral perfusion 56 glucose intolerance 56 serum urate 56 elevated prolactin 56 clinically meaningful improvements 56 lowering triglyceride levels 56 prognostic significance 56 folate vitamin B 56 beta blocker atenolol 56 LDL oxidation 56 postoperative mortality 56 folate concentrations 56 nonalcoholic steatohepatitis NASH 56 PROactive study 56 postprandial insulin 56 systolic blood pressures 56 metabolic alterations 56 CD4 + cell 56 MDRD 56 hs CRP 56 receptor subtypes 56 beta blocker therapy 56 basal metabolic rate 56 sperm motility 56 concomitant medications 56 isolated systolic hypertension 56 ACEIs 56 dietary folate intake 56 thyroid stimulating hormone TSH 56 Statin therapy 56 colorectal neoplasia 56 hemoglobin A1c 56 abdominal girth 56 #.#mmol L [002] 56 thyroid function 56 symptom exacerbation 56 L carnitine 56 analgesic efficacy 56 T1 weighted images 56 trandolapril 56 platelet aggregation 56 cholesterol 56 P = .# 55 fasting hyperglycemia 55 lowering LDL cholesterol 55 NATRECOR R 55 Apidra ® 55 Vildagliptin 55 albuminuria 55 nattokinase 55 covariate 55 type2 diabetes 55 EQ 5D 55 quetiapine Seroquel 55 antiarrhythmic medications 55 serum testosterone 55 inotropic 55 mm Hg diastolic 55 ABCB1 55 diabetic kidney 55 ezetimibe Zetia 55 ketogenic 55 serum phosphorus 55 posttest 55 lowers triglycerides 55 recurrent venous thromboembolism 55 tryptase 55 spontaneous preterm delivery 55 DHEAS 55 pharmacokinetic characteristics 55 lipids 55 thiazolidinediones TZDs 55 serum IgE 55 NNRTI resistance 55 nutritional supplementation 55 regulates blood glucose 55 LDL C 55 Multivariate analyzes 55 dietary nitrate 55 non fasting triglycerides 55 serum markers 55 NRF2 gene 55 monounsaturated fatty acids 55 titrated glipizide 55 tirofiban 55 ventilatory 55 HAQ DI 55 Caloric restriction 55 pravastatin Pravachol 55 baseline serum creatinine 55 nicardipine 55 PSADT 55 folates 55 myocardial function 55 skeletal muscle mass 55 diuretic chlorthalidone 55 QT intervals 55 prognostic indicators 55 aspirin NSAIDs 55 nonvertebral fracture 55 Plant sterols 55 orthostatic hypotension 55 isoflavone supplement 55 risedronate Actonel 55 soy phytoestrogens 55 anthropometric measurements 55 OGTT 55 Meta analyzes 55 ACTOplus met XR 55 NIHSS 55 calcium intake 55 acid supplementation 55 plasma cortisol 55 coronary stenosis 55 vaginal flora 55 density lipoprotein HDL cholesterol 55 Randomized trials 55 hypoglycemia unawareness 55 Aldosterone 55 corneal thickness 55 morbidly obese adolescents 55 nutrient supplementation 55 cystatin C 55 QTc interval 55 noncardiovascular mortality 55 nmol l 55 kidney function 55 skin sterol 55 DHA supplementation 55 serum testosterone levels 55 obesity insulin resistance 55 Leitzmann 55 Plasma concentrations 55 dopaminergic therapy 55 PYY3 55 cranial irradiation 55 plasma lipid profiles 55 haematologic 55 prepubertal 55 test OGTT 55 Vitamin D supplementation 55 insulin lispro 55 erectile function 55 STRIDE PD 55 triglyceride concentration 55 hypertensive rats 55 LYSTEDA 55 Pharmacokinetic 55 intracerebral haemorrhage 55 UKPDS 55 aspirin clopidogrel 55 Bone density 55 abstinent alcoholics 55 nonsignificant trend 55 malondialdehyde MDA 55 logistic regression analysis 55 TZDs 55 lipid elevations 55 lowers LDL 55 hemoglobin hematocrit 55 #mg/day [001] 55 guggul 55 pharmacokinetic interaction 55 leukocyte count 55 convergent validity 55 gallstone formation 55 colon rectal 55 blood glucose 55 hypocaloric diet 55 Fibrates 55 serotonin synthesis 55 hemodialysis patients 55 colorectal adenomas 55 experimentally induced 55 liver transaminases 55 escitalopram Lexapro 55 reactive hyperemia 55 potential confounders 55 statistically nonsignificant 55 SE alleles 55 pharmacodynamic endpoints 55 prolactin elevation 55 NAT2 55 Alpha lipoic acid 55 gut microflora 55 lipid lowering drugs 55 tumor perfusion